ENOUGH has secured €40 million in growth funding to expand its mycoprotein production capabilities, positioning itself as a leader in the sustainable protein market.

Target Information

ENOUGH is a leading food technology company specializing in large-scale mycoprotein production, having pioneered the production of its proprietary ingredient, ABUNDA®. This high-protein alternative can be utilized in a variety of products, including plant-based chicken, mince, and dairy. Founded in 2015, ENOUGH addresses the increasing global demand for sustainable protein through the fermentation of fungi using renewable feedstocks, which enables the mass production of a nutritious ingredient that is both versatile and environmentally friendly.

ENOUGH's ABUNDA® mycoprotein is produced utilizing innovative technology that requires significantly fewer resources. It is estimated to be up to 15 times more efficient than beef in terms of resource use, requiring 93% less water, 97% less feed, and generating 97% fewer CO2 emissions. With partnerships established with notable brands such as M&S and Unilever, ENOUGH aims to transform diets globally by providing sustainable protein solutions.

Industry Overview

The global food industry faces pressing challenges, particularly in relation to the environmental impact of meat production, which accounts for nearly 15% of greenhouse gas emissions—one of the largest sources of methane and deforestation. Concurrently, interest in alternative p